Product Images Pregabalin

This is a formula used to estimate creatinine clearance in patients by using their age, weight, and serum creatinine levels. The formula adjusts the result for female patients by multiplying it by a factor of 0.85.*

This is a chart that displays the percentage of patients who improved their pain symptoms from a baseline measure, with different daily doses of pregabalin and a placebo. The chart shows that a daily dose of 600mg of pregabalin had the highest percentage of improvement, as compared to doses of 450mg and 300mg, and the placebo.*

This appears to be a graph displaying the results of a study or experiment involving the drug Pregabalin and a placebo. The graph shows various percentages ranging from 10% to 100%, with corresponding percentages of effectiveness or some other variable. However, due to the presence of non-English characters and seemingly incomplete or nonsensical textual elements, further details are not available.*

The text shows a table with the percent of subjects improved in a study comparing the drug Pregabal to a placebo. The data includes the percentage improvement from baseline to week 12 using the BOFC measure. The table includes values for subjects at different time points (w04, 210, 220, 230, 250, 260, and 270) and for both Pregabal and Placebo groups.*

This appears to be a medication label containing information about Pregabalin capsules with NDC 0228285603. It suggests to print medication guides from a website, and provides dosing information and prescribing details. The medication guide is described as being included in the container, and there is also some information about storage temperature. The capsules are manufactured by Teva Pharmaceuticals in Persippany, NJ.*

This is a description of Pregabalin capsules with NDC (National Drug Code) 0228-2857-08. The medication is dispensed with an accompanying Medication Guide for each patient by a pharmacist. The usual dosage is mentioned on the prescribing information. The capsules contain 50mg of Pregabalin, USP. The medication must be stored in a tight, light-resistant container at a temperature between 15 to 30°C. The manufacturer of the medication is Teva Pharmaceuticals, and the lot number is 0228-2857-09. Serialization coding area is also present.*

This is a medication guide for Pregabalin capsules, NDC 0228-2858-09, manufactured by Teva Pharmaceuticals. Each capsule contains 75mg of Pregabalin, USP. The medication guide should be given to each patient along with usual prescribing information. Dispense the medication in a tight, light-resistant container and store at 25°C (77°F) with excursions permitted to 15 to 30°C (58 to 86°F) as defined by the USP. The package contains 90 capsules and the GTIN is 0302282858097. The document also includes a serialization coding area and lot expiration details.*

NDC 0228-2859-09 is the code for Pregabalin capsules to be dispensed by a pharmacist with a prescription, and it contains 90 capsules with 100mg per capsule. The prescribing information should be consulted for dosage instructions. The medication should be stored in a tightly sealed container at room temperature within a specific range. This medication is manufactured by Teva Pharmaceuticals in Parsippany, N.J. The document also includes a medication guide to be printed from a website.*

This is a medication guide for Pregabalin capsules with NDC 0228:2860-09. The pharmacist is required to dispense this guide to each patient along with Rx for 90 capsules. Each capsule contains 150mg of Pregabalin, and the usual dosage is mentioned in the prescribing information. The capsules must be stored in a tight, light-resistant container at 25°C, with excursions permitted at 15 - 30°C as per the USP Controlled Room Temperature. The medication is manufactured by Teva Pharmaceuticals, and the guide can be printed from tevausa.com/medguides. However, the last few lines are not readable.*

This is a description of Pregabalin capsules produced by Teva. The medicine is dispensed through prescription only and comes in a packaging of 90 capsules. The medication guide should be given to each patient by the pharmacist. Each capsule contains 200mg of Pregabalin. The usual dosage information is provided in the accompanying prescribing information. The capsules should be stored in a light-resistant container following the guidelines mentioned in the USP. The medicine is manufactured by Teva Promaceuricas, located in Parsippany, NJ. In case of any queries, the medication coding area is mentioned along with the serial number.*

This is a medication for Pregabalin, indicated for the treatment of nerve pain caused by certain conditions such as spinal cord injury, diabetes, and shingles. It comes in capsule form, with 90 capsules in each container. It should be dispensed by a pharmacist with an accompanying medication guide. The medication should be stored in a tightly sealed container and at controlled room temperature. The text provides the manufacturer's information and the usual dosage. The product has a GTIN code for traceability.*

This is the label for a prescription drug called Pregabalin, which is sold in a bottle of 90 capsules. Each capsule contains 300mg of Pregabalin, which is a common dosage. Pharmacists must dispense an accompanying Medication Guide to each patient. Teva Pharmaceuticals manufactured this drug and it should be stored in a tight, light-resistant container at 25°C (77°F). The label includes a GTIN (Global Trade Item Number) and a product code (NDC0226-2863.09).*

This appears to be a chart showing the percent of patients who experienced an improvement in pain, with the percentages ranging from 10 to an unclear number due to the poor quality of the . The heading also mentions improvement from a baseline.*

The text describes a chart or table for measuring pain improvement in patients based on the administration of a medication called Pregatin in different doses and frequencies. The percentage of improvement in pain from baseline is shown in the table.*

The text represents a table showing the Responder Rate percentage for different studies and treatments. The table compares the effects of various doses of a medication to Placebo. The Responder Rate ranges from 0% to 60%. The medication is evaluated in different dosages such as 50 mg/day, 150 mg/day, 300 mg/day, and 600 mg/day. The study has been conducted in several trials such as E1 and E3 of which the 60% Responder Rate is statistically significant compared to Placebo.*